Affinity Asset Advisors »

Eliem Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 1.7M 7.11

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
BlackRock
Vanguard Group
Sphera Funds Management
Ikarian Capital
TD Asset Management
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Eliem Therapeutics